1Barnett AH, et al (eds). Hypertension and Diabetes. 3rd ed. London: Science Press, 2000.
2Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003,289:2560-2572.
3Kannel WB, D'Agostino RB, Wilson PW, et al. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J, 1990,120:672-676.
4Hypertension in Diabetes Study (HDS): Ⅱ. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens, 1993,11:319-325.
5Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ, 1998,317:713-720.
6Moor TJ. DASH diet. Curr Opin Endocrinol Diabetes, 2004,11:158-163.
7Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens, 2000,18:1149-1154.
8ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 2002,288:2981-2997.
9Julius S. The Hypertension Optimal Treatment (HOT) Study in the United States. Am J Hypertens, 1996,9:41S-44S.
10Baba S; J-MIND Study Group. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics. Diabetes Res Clin Pract, 2001,54:191-201.
6Hillier TA,Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes:the relation of obesity and age of onset[J]. Diabetes Care,2001,24(9) : 1522-1527.
7Burns N,Finueane FM, Hatunie M, et al. Early-onset type 2 dia- betes in obese white subjects is characterised by a marked defect in β cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training[J]. Diabetologia, 2007, 50 (7) : 1500-1508.
8Bell RA,Smith SL,Arcury TA,et aL Prevalence and correlates of depressive symptoms among rural older African Americans,Native Americans,and whites with diabetes.Diabetes Care,2005,28:823-829.
9Nguyen TT,WongTY,Islam FM,et al.Is depression associated with microvascular disease in patients with type 2 diabetes? Depress Anxiety,2008,25:E158-E162.
10Peyrot M,Rubin RR.Levels and risks of depression and anxiety symptomatology among diabetic adults.Diabetes Care,1997,20:585-590.
